.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Healthtrust
UBS
Cantor Fitzgerald
Novartis
Colorcon
Teva
Cerilliant
Covington

Generated: July 24, 2017

DrugPatentWatch Database Preview

ABREVA Drug Profile

« Back to Dashboard

What is the patent landscape for Abreva, and when can generic versions of Abreva launch?

Abreva is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in ABREVA is docosanol. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the docosanol profile page.

Summary for Tradename: ABREVA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list73
Patent Applications: see list6,837
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ABREVA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
ABREVA
docosanol
CREAM;TOPICAL020941-001Jul 25, 2000OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ABREVA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
ABREVA
docosanol
CREAM;TOPICAL020941-001Jul 25, 2000► Subscribe► Subscribe
Glaxosmithkline
ABREVA
docosanol
CREAM;TOPICAL020941-001Jul 25, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Colorcon
McKinsey
Julphar
Accenture
Dow
Chinese Patent Office
Moodys
US Army
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot